Vitamin A (Retinol): Evidence-Based Ways to Improve Your Levels

At a glance
- Normal serum retinol range / 30 to 65 mcg/dL (1.05 to 2.27 micromol/L)
- Deficiency threshold (WHO) / below 20 mcg/dL (0.70 micromol/L)
- Toxicity concern / above 65 mcg/dL, or chronic intake commonly cited above 25,000 IU/day
- Very high-retinol food / beef liver, roughly 6,400 mcg RAE per 3 oz serving
- Beta-carotene conversion ratio / about 12:1 (mcg beta-carotene to mcg retinol activity equivalent)
- RDA for adult men / 900 mcg RAE (3,000 IU)
- RDA for adult women / 700 mcg RAE (770 mcg RAE if pregnant)
- Tolerable Upper Intake Level / 3,000 mcg (10,000 IU) preformed retinol daily
- Typical time to correct deficiency / weeks to a couple of months with therapeutic dosing under supervision
- Key risk populations / bariatric surgery patients, people with fat malabsorption (Crohn's, chronic pancreatitis, cystic fibrosis, cholestatic liver disease), chronic alcohol use
What Serum Retinol Actually Measures
Serum retinol reflects circulating vitamin A bound to retinol-binding protein (RBP), not your total body stores. This distinction matters. The liver holds the large majority of the body's vitamin A reserve, and serum levels tend to stay in the normal range until hepatic stores are already significantly depleted 1. A "normal" blood test does not guarantee adequate reserves, and a low result generally means stores are already meaningfully depleted.
The World Health Organization defines biochemical deficiency as serum retinol below 0.70 micromol/L (20 mcg/dL) 2. Values between 20 and 30 mcg/dL indicate marginal status. Biochemical deficiency is uncommon in the general U.S. adult population, but specific groups carry substantially higher risk. Patients who have had bariatric surgery are one well-documented example, with published deficiency rates reported to run much higher than in the general population, varying by procedure type and time since surgery.
Fasting is preferred before testing, since a recent meal can transiently raise measured retinol. Acute infection and systemic inflammation suppress RBP synthesis, driving retinol down independent of true stores, so a C-reactive protein check is reasonable if a low result seems out of line with a person's diet and history.
How to Raise Low Vitamin A Levels
If your retinol sits below 30 mcg/dL, the usual goal is repletion through preformed vitamin A (retinyl palmitate or retinyl acetate), not beta-carotene alone. Preformed retinol absorbs efficiently and consistently, while beta-carotene conversion varies widely between individuals depending on genetics, gut health, and how the food is prepared, according to nutrition research on vitamin A metabolism.
Dietary repletion:
Beef liver (3 oz) is unusually concentrated, delivering roughly 6,400 mcg RAE per serving according to USDA-derived values in the NIH Office of Dietary Supplements fact sheet 13. Cod liver oil is similarly concentrated per teaspoon. Whole milk, eggs, and fortified cereals contribute smaller but meaningful amounts and work well as maintenance sources once levels are adequate.
Supplementation:
Bariatric nutrition guidelines generally recommend 5,000 to 10,000 IU (1,500 to 3,000 mcg RAE) of preformed vitamin A daily for post-bariatric patients when serum retinol falls below 30 mcg/dL. This guidance is specific to that surgical population and should not be extrapolated to everyone with a low result.
For severe deficiency with clinical signs (night blindness, xerophthalmia), the WHO treatment protocol calls for high-dose oral vitamin A (200,000 IU) on two consecutive days followed by maintenance dosing 2. This regimen is documented primarily in settings of endemic deficiency and pediatric xerophthalmia; in a well-nourished adult in the US with a mild lab abnormality and no eye symptoms, this dose is very unlikely to be appropriate, and dosing should be set by a clinician based on the clinical picture, not the number alone.
Recheck serum retinol after several weeks of repletion. Overshoot is possible, and preformed vitamin A carries real hepatic risk at high or prolonged intake, so self-directed high-dose supplementation is not advisable.
How to Lower Elevated Vitamin A Levels
Hypervitaminosis A occurs from preformed retinol (supplements, liver, cod liver oil), not from beta-carotene. Beta-carotene does not cause vitamin A toxicity; high intake can cause harmless yellow-orange skin discoloration (carotenodermia) instead. Chronic toxicity is most often described at daily intakes in the tens of thousands of IU sustained over months to years, though individual susceptibility varies 6.
If your retinol is above 65 mcg/dL:
Stop all vitamin A-containing supplements, including multivitamins, cod liver oil, and skin or hair supplements containing retinyl palmitate. Mention any topical retinoid use to your clinician, particularly with large surface area application, since systemic absorption is possible though usually minor. Recheck levels after several weeks; how quickly retinol falls depends on how much excess has accumulated in the liver.
If levels exceed 100 mcg/dL, or liver enzymes are elevated, prompt medical evaluation and possible hepatology referral is reasonable clinical practice. Chronic hypervitaminosis A can cause liver scarring that may not fully reverse even after supplements are stopped 7.
Vitamin A Decision Framework
| Your situation | What it likely means | Reasonable next step | Exception to watch for |
|---|---|---|---|
| Retinol 30 to 65 mcg/dL, no symptoms | Adequate status | No action needed; retest only if a new risk factor appears | Recent infection or inflammation can transiently push a true-normal result down; check CRP if the result seems inconsistent with your diet |
| Retinol 20 to 30 mcg/dL | Marginal status | Add preformed vitamin A foods (liver, dairy, eggs); recheck in roughly 2 to 3 months before considering supplements | If you are pregnant or may become pregnant, avoid high-dose supplements even at this stage; work with your clinician |
| Retinol below 20 mcg/dL | Biochemical deficiency by WHO criteria | Discuss preformed retinol repletion with a clinician; investigate a fat malabsorption cause if diet does not explain it | Bariatric surgery, Crohn's disease, chronic pancreatitis, cystic fibrosis, and alcohol use disorder all raise the likelihood of a malabsorptive cause |
| Retinol above 65 mcg/dL | Possible excess, usually from supplements | Stop all preformed vitamin A supplements; recheck retinol and liver enzymes in a few weeks | Beta-carotene-rich foods (carrots, sweet potatoes, leafy greens) are not the cause and do not need to be restricted |
| Retinol above 100 mcg/dL, or elevated liver enzymes at any retinol level | Possible early hepatotoxicity | Seek prompt medical evaluation; hepatology referral may be warranted | Chronic alcohol use narrows the safety margin further and deserves earlier, closer follow-up |
| Planning pregnancy or currently pregnant | RDA for pregnancy is 770 mcg RAE | Get vitamin A mainly from food; avoid prenatal or general supplements with high-dose preformed retinol | High-dose preformed vitamin A in early pregnancy is linked to increased birth defect risk; beta-carotene is not |
| Taking oral isotretinoin | Already receiving a synthetic retinoid | Do not add separate vitamin A supplements | Additive toxicity risk; this applies even if a supplement is marketed for skin or hair |
Use this table as a basis for discussing vitamin A levels with your clinician rather than as a replacement for personalized medical guidance, particularly when retinol is substantially decreased, substantially elevated, or occurs alongside abnormal liver function.
The Fat Absorption Connection
Vitamin A is fat-soluble. Without adequate bile salts and pancreatic lipase, absorption drops regardless of intake. This is why certain conditions reliably produce vitamin A deficiency even with reasonable dietary intake.
Crohn's disease affecting the terminal ileum reduces bile salt recycling, and studies of patients with Crohn's disease in remission have found a meaningful share with biochemically low serum retinol; exact prevalence figures vary by cohort and should be checked against the primary study before being cited as a fixed rate 8. Chronic pancreatitis with exocrine insufficiency impairs micellar solubilization, and cholestatic liver disease can block bile secretion significantly enough to blunt absorption on its own.
For patients with documented fat malabsorption, water-miscible (aqueous) vitamin A preparations are generally reported to absorb better than standard oil-based capsules, though the exact size of the improvement varies by study and clinical setting. Pairing supplementation with pancreatic enzyme replacement therapy at meals can further improve uptake. European pediatric and adult cystic fibrosis nutrition guidelines (ESPEN-ESPGHAN-ECFS) recommend water-miscible vitamin A for CF patients with pancreatic insufficiency 10.
Genetic Variation in Beta-Carotene Conversion
Not everyone converts plant-based carotenoids to retinol with equal efficiency. The BCO1 gene encodes the rate-limiting enzyme in that conversion. A study in the FASEB Journal identified common variants (including rs12934922 and rs7501331) that meaningfully reduce conversion efficiency in people carrying two copies, with the reduction reported in the range of roughly one-third to two-thirds depending on genotype combination 11. Estimates from that literature suggest a substantial share of the population carries at least one variant allele, though the precise population frequency is worth confirming against the primary source before it is stated as a hard number.
Practical implication: if serum retinol stays below 30 mcg/dL despite a diet rich in carrots, sweet potatoes, and leafy greens, poor beta-carotene conversion is a plausible explanation. Preformed retinol sources (or a modest, clinician-guided supplement) address this more reliably than more plant carotenoids.
Alcohol, Liver Disease, and Vitamin A: A Narrower Safety Margin
Chronic alcohol use depletes hepatic vitamin A stores through several mechanisms, including faster catabolism via alcohol-metabolizing enzymes, reduced RBP synthesis, and direct toxicity to the liver's vitamin A-storing stellate cells 12. The complication is that supplementation in these patients carries its own hepatotoxicity risk, because alcohol and retinol are processed through overlapping liver pathways, and combining them can amplify oxidative liver stress. Leo and Lieber's review of these interactions is the frequently cited source describing this narrowed safety window in people with ongoing heavy alcohol use 12.
Because of this, clinicians treating a patient with alcohol use disorder and confirmed vitamin A deficiency often favor more conservative repletion doses, closer to the RDA than to bariatric-style repletion doses, along with more frequent liver-function monitoring, rather than following a fixed universal protocol. The NIH Office of Dietary Supplements is a useful general reference on vitamin A safety when discussing this with a clinician 13.
Vitamin A and Bone Health
Excessive preformed vitamin A intake has been linked to reduced bone mineral density and increased fracture risk in observational research. The Nurses' Health Study found that women with the highest preformed vitamin A intake (above roughly 3,000 mcg RAE daily from food and supplements combined) had a meaningfully higher hip fracture risk than women with the lowest intake, with a relative risk near 1.5 14. This is observational data showing an association, not a randomized trial proving that lowering intake prevents fractures. Beta-carotene showed no such association in the same cohort.
Given this, postmenopausal women already taking a preformed vitamin A supplement on top of a normal diet are a reasonable group to flag intake as one factor worth discussing during a broader fracture-risk conversation with a clinician, alongside calcium, vitamin D, and bone density screening.
Pregnancy Considerations
Retinol is teratogenic at high doses. Rothman and colleagues' large NEJM cohort study (over 22,000 pregnancies) found a meaningfully elevated risk of certain birth defects among women taking high-dose preformed vitamin A, roughly in the range of 10,000 to 15,000 IU per day or more, very early in pregnancy 16 16b. The exact dose threshold and the precise relative risk are worth confirming against the primary paper before being quoted as a single fixed figure in patient-facing material; this is a case where the direction and general magnitude of risk are well established, but the exact numbers deserve a direct source check.
ACOG's guidance on nutrition during pregnancy advises getting vitamin A mainly from food and beta-carotene-rich sources, and keeping supplemental preformed retinol at or near the pregnancy RDA of 770 mcg RAE rather than taking high-dose supplements 17. Prenatal vitamins with unusually high preformed retinol content are worth flagging to a prescriber; beta-carotene-based formulations avoid this concern entirely.
Monitoring Schedule
After starting a repletion or reduction plan, a reasonable general cadence looks like this, adjusted by your clinician based on how abnormal the starting value was and your underlying cause:
For deficiency repletion: recheck serum retinol after roughly 2 to 3 months. Once two consecutive results land in the normal range, annual monitoring is usually sufficient unless an underlying malabsorption condition persists, in which case follow-up should be individualized with the treating specialist.
For toxicity reduction: recheck retinol along with AST, ALT, and alkaline phosphatase every few weeks until retinol normalizes and liver enzymes are stable. Imaging (ultrasound or elastography) is reasonable if enzymes stay elevated after retinol comes down.
For bariatric surgery patients specifically, published perioperative nutrition guidelines call for ongoing micronutrient monitoring on a roughly annual to twice-yearly basis depending on procedure type. Other at-risk groups, including those with cystic fibrosis or ileal Crohn's disease, should follow the monitoring schedule set by their treating specialist rather than a one-size-fits-all interval.
For context on population-level impact, a Cochrane review of vitamin A supplementation in children (covering roughly 47 trials) found supplementation reduced all-cause mortality by about 12% in populations with endemic deficiency 18. This evidence is about public health supplementation programs in high-deficiency settings, mostly outside adult clinical care in the US, but it underscores why correcting genuine deficiency matters.
Frequently asked questions
What is a normal Vitamin A (retinol) level?
What does a high Vitamin A (retinol) mean?
What does a low Vitamin A (retinol) mean?
Can I get enough Vitamin A from vegetables alone?
How much Vitamin A is too much?
Does Vitamin A supplementation help acne?
How long does it take to correct Vitamin A deficiency?
Should I take Vitamin A with food?
Can Vitamin A affect my bones?
Is Vitamin A safe during pregnancy?
What medications affect Vitamin A levels?
Do I need to fast before a Vitamin A blood test?
References
- Olson JA. Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J Natl Cancer Inst. 1984;73(6):1439-44. https://pubmed.ncbi.nlm.nih.gov/6439934/
- World Health Organization. Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO Global Database on Vitamin A Deficiency. 2009. https://www.who.int/publications/i/item/9789241594929 )
- Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191-201. https://pubmed.ncbi.nlm.nih.gov/16469975/
- Nollevaux MC, et al. Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. Liver Int. 2006;26(2):182-6. https://pubmed.ncbi.nlm.nih.gov/16448456/
- Filippi J, et al. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006;12(3):185-91. https://pubmed.ncbi.nlm.nih.gov/16534419/
- Argao EA, et al. d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin A in patients with cholestasis. J Pediatr Gastroenterol Nutr. 1992;14(3):257-264. https://pubmed.ncbi.nlm.nih.gov/9701160/
- Turck D, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557-577. https://pubmed.ncbi.nlm.nih.gov/27068495/
- Leung WC, et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 2009;23(4):1041-53. https://pubmed.ncbi.nlm.nih.gov/19103647/
- Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69(6):1071-85. https://pubmed.ncbi.nlm.nih.gov/10357725/
- National Institutes of Health Office of Dietary Supplements. Vitamin A and Carotenoids - Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
- Feskanich D, et al. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287(1):47-54. https://pubmed.ncbi.nlm.nih.gov/11754708/
- Shoback D, et al. Endocrine Society clinical practice guideline on pharmacological management of osteoporosis. J Clin Endocrinol Metab. 2024. https://pubmed.ncbi.nlm.nih.gov/38828931/ (verify claim-level fit for the fracture-risk assessment statement before publishing)
- Rothman KJ, et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-73. https://pubmed.ncbi.nlm.nih.gov/7477116/ and https://www.nejm.org/doi/full/10.1056/NEJM199511233332101 (confirm exact dose threshold and relative risk figure against the primary paper before publishing)
- American College of Obstetricians and Gynecologists. Nutrition During Pregnancy. ACOG Committee Opinion. 2023. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2023/06/nutrition-during-pregnancy
- Imdad A, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017;3(3):CD008524. https://pubmed.ncbi.nlm.nih.gov/28282701/
